Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
about
Intermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adultsCombined corticosteroid and long-acting beta-agonist in one inhaler for chronic asthmaIntermittent inhaled corticosteroid therapy versus placebo for persistent asthma in children and adultsIntermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsIntermittent versus daily inhaled corticosteroids for persistent asthma in children and adultsEarly use of inhaled corticosteroids in the emergency department treatment of acute asthmaInhaled steroids for acute asthma following emergency department dischargeAddition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and childrenAddition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthmaAddition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and childrenLong-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthmaAddition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adultsLong-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and childrenLong-acting beta2-agonists for chronic asthma in adults and children where background therapy contains varied or no inhaled corticosteroidLong-acting beta2-agonists for stable chronic asthmaEarly use of inhaled corticosteroids in the emergency department treatment of acute asthmaLong-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthmaPharmacotherapy and airway remodelling in asthma?Asthma exacerbations . 1: epidemiologyAdd-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive reviewKorean Asthma Guideline 2014: Summary of Major Updates to the Korean Asthma Guideline 2014Nano-Therapeutics for the Lung: State-of-the-Art and Future PerspectivesReal-world research and its importance in respiratory medicineImpact of extrafine formulations of inhaled corticosteroids/long-acting beta-2 agonist combinations on patient-related outcomes in asthma and COPD.Is there still hope for single therapies: how do we set up experimental systems to efficiently test combination therapies?Tiotropium in asthma: what is the evidence and how does it fit in?Potential mechanisms to explain how LABAs and PDE4 inhibitors enhance the clinical efficacy of glucocorticoids in inflammatory lung diseasesImprovement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trialEffect of leukotriene receptor antagonist therapy on the risk of asthma exacerbations in patients with mild to moderate asthma: an integrated analysis of zafirlukast trialsDose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysisBone mineral density in subjects with mild asthma randomised to treatment with inhaled corticosteroids or non-corticosteroid treatment for two yearsChronic asthma.Loss of asthma control in pediatric patients after discontinuation of long-acting Beta-agonistsCan the anti-inflammatory activities of β2-agonists be harnessed in the clinical setting?Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendationsAdd-on LABA in a separate inhaler as asthma step-up therapy versus increased dose of ICS or ICS/LABA combination inhalerNational Athletic Trainers' Association position statement: management of asthma in athletes.Asthma outcomes: exacerbationsDeterioration in asthma control when subjects receiving fluticasone propionate/salmeterol 100/50 mcg Diskus are "stepped-down".Options for bronchodilation in children: can we rely on adult data?
P2860
Q24186347-2F45F628-5BA5-4C9B-B115-8EAD218D750CQ24194706-CDD791DC-B774-410C-892B-9041D63A443CQ24197698-24646EE3-B16D-4559-BCB3-AE54103994F9Q24200804-0B81694A-F57C-442E-B863-336AB3074261Q24202489-881EA7DD-125D-4C28-AC31-B3EEBFFB3210Q24202511-9B03A2A8-BA90-4BC1-B409-D03D3D0C7AB4Q24202560-A88BBDC3-37D8-4AF1-9330-342B90C4DD82Q24235303-67A01F42-B2FF-45D5-8D20-A879CF33FFBAQ24235964-769539EA-28D0-45CB-B38E-2D593421827CQ24240464-897064B0-98EF-418C-8535-9B68ECFF6B26Q24244152-3C307284-B3FA-41D8-84F2-BE9C1016DE04Q24245719-20D69C81-FC9F-44F5-A1C1-96A450AD69FFQ24245892-A0DE1D1B-1B3F-4ADE-AFD8-6ADA7EA2E60EQ24246441-D58511BB-ED6D-4E6E-95CB-EF6FCA22AD1EQ24247926-9E5E1E4D-6A88-4021-9BAC-DAF4219BBA60Q24247958-E863E155-1B02-4879-99B7-11893155BAFEQ24634033-333F8886-697D-4D76-AE5B-2FC2B3C839ECQ24678822-BE1A27C7-1048-43FF-B11F-D174A354D3E7Q24683608-B9AF8B3E-9561-4BD0-8235-4C83014C03AFQ24794527-22C9735A-7DB4-4A6B-96CA-F2398CB2499AQ26739011-556B0A67-11F7-46DD-A8F8-4FBBB61CF5D4Q26786162-DAAF1C2E-5F85-4D4F-8F83-67551241D241Q26797460-234B0317-E9A7-43CC-980D-CF20FB46A4B7Q26826860-C0905387-EEB8-4B66-AE36-627319EC1477Q26998459-94A70C91-E03A-4A4A-90B6-47427DF1F436Q28067912-68252A2D-7097-426F-AD55-4CECBED3B07AQ28083987-C677444F-B714-49A0-80ED-5A6A2C8AF000Q28192038-E7F20218-05CB-4D02-8EC2-091ECA6042D7Q28344299-FC573251-8435-4D28-A9A4-F479DA731B96Q28345332-03D70E71-834F-4B53-B18C-A69A7E523F2AQ28360535-53EF58AA-0405-453E-832A-884FD86B782EQ28362642-1590A158-7639-42F3-BA63-95CA72B6C677Q28388214-4205A25E-B935-4039-937F-01C8CDDF1D86Q28391808-B98437CA-F98D-4108-AA17-91307CFB4ABEQ28392274-0781141B-D0A8-4711-86BB-13F9FEA8A776Q28596628-665D2877-29E0-40EB-A0AA-5FFBA07915FFQ28769235-AC2E1190-3F49-4928-B525-1C721740EB8EQ30421935-A3428162-536B-476F-856F-74414436F878Q30447195-87F1C050-1F8C-4046-B367-6CFA66EF57BCQ30579833-EBBB53F7-FE15-4716-A4DA-0D24C4A3ACD8
P2860
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Effect of inhaled formoterol a ...... ET) International Study Group.
@en
Effect of inhaled formoterol a ...... osteroids Establishing Therapy
@nl
type
label
Effect of inhaled formoterol a ...... ET) International Study Group.
@en
Effect of inhaled formoterol a ...... osteroids Establishing Therapy
@nl
prefLabel
Effect of inhaled formoterol a ...... ET) International Study Group.
@en
Effect of inhaled formoterol a ...... osteroids Establishing Therapy
@nl
P2093
P1476
Effect of inhaled formoterol a ...... ET) International Study Group.
@en
P2093
A E Tattersfield
C G Löfdahl
D S Postma
P J Barnes
R A Pauwels
P304
P356
10.1056/NEJM199711133372001
P407
P577
1997-11-01T00:00:00Z